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The dimeric tryptophanyl-tRNA synthetase from beef pancreas has been found to activate 2 
tryptophans/mol enzyme [Eur. J. Biochem. (1982) 128, 389-3981. By using quenched-flow and stopped- 
flow methods under presteady-state conditions, we show that only one enzyme subunit operates at a time 
in the aminoacylation of tRNATW and that the transfer reaction is not the rate-limiting step in the overall 
aminoacylation process. 
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1. INTRODUCTION 
Tryptophanyl-tRNA synthetase from beef pan- 
creas, an cYz-dimeric enzyme [1,2], has the follow- 
ing binding and kinetic properties: 
(i) It binds non-covalently 2 mol tryptophan in 
an anticooperative way (& = 1 and 20 FM [3]). 
However, it can also bind 1 mol tryptophan 
covalently [4]. 
(ii) It binds non-covalently 2 mol tryptophanyl 
adenylate [5,6]. 
(iii) From the pyrophosphate concentration 
dependence of tryptophanyl adenylate pyrophos- 
phorolysis it has been inferred that 2 pyrophos- 
phate molecules can be bound, both having the 
same affinity for the enzyme adenylate complex 
and that these 2 adenylates are bound in an equi- 
valent way [7]. However, a covalent monopyro- 
phosphoryl enzyme has also been described [8]. 
(iv) It binds 2 molecules of tRNATW [9] in an 
anticooperative way [lo] (& -300 nM and 
1 rM [lOI). 
Both subunits therefore appear to be able to bind 
all substrates and products of the aminoacylation 
reaction. 
* To whom correspondence should be addressed 
(v) Kinetically it makes the 2 tryptophanyl 
adenylates with an anticooperative dependence on 
tryptophan concentration that closely follows the 
binding of tryptophan [7] and with a Michaelian 
dependence on ATP-Mg*+ concentration [7]. The 
anticooperative kinetics of adenylate synthesis 
have been alternatively attributed to the slow 
release of one high affinity pyrophosphate 
molecule from the enzyme [ 111. 
The aminoacylation reaction when carried out 
under steady state conditions shows a Michaelian 
dependence of the rate on tRNA concentration 
1121. It is not known whether a single site or two 
sites are involved in this reaction though both 
adenylates are thought to be identically available. 
On the grounds of chemical modifications of the 
enzyme by tRNA derivatives [lo] and ATP 
derivatives [13] half-of-the-sites reactivity has been 
suggested. 
The aminoacylation steady state rate constant 
(6.5 s-’ for the dimer [9]) is much lower than the 
amino acid activation rate constant measured in 
the absence of tRNA (40 s-‘/subunit [7]). This 
suggests that the transfer reaction of tryptophan 
from the adenylate to tRNA or the dissociation of 
tryptophanyl-tRNA from the enzyme should be 
strongly rate limiting, providing the adenylate for- 
mation is not slowed down by tRNA. Since no at- 
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tempt has yet been made to study this transfer 
reaction no definite conclusion has emerged about 
the role of each subunit in the aminoacylation 
reaction. 
The present study has been aimed at the follow- 
ing questions: 
(1) Are both subunits active in the aminoacylation 
reaction as they are in the activation reaction? 
(2) Is the transfer of tryptophan the rate-limiting 
step in the overall aminoacylation? 
Here, we study the aminoacylation reaction of 
beef tRNATn’ by tryptophanyl-tRNA synthetase 
from beef pancreas under prestationary condi- 
tions, using quenched-flow and stopped-flow 
methods. 
2. MATERIALS AND METHODS 
Tryptophanyl-tRNA synthetase was prepared as 
in [ 121. Its concentration was determined by absor- 
bancy (6~8~ = 9 x 104 M-l. cm-‘) [14]. tRNATv 
from beef liver was prepared as in [15]. The amino 
acid acceptance was 1400 pmo1/260 absorbancy 
unit. The tRNATm concentration was calculated 
taking this value into account. 
PPi (500 units/mg) was from Sigma, L- 
[‘4C]tryptophan (58 mCi/mol) was from Amer- 
sham. All other chemicals were from Merck. 
The experiments were performed in 100 mM 
Tris-HCl buffer (pH 8) containing 0.1 mM EDTA 
and 1 mM DTE, at 25°C. Mg2+ was 1 mM based 
on Kd = 15 /cM for ATP-Mg2+ [ 161. The quenched- 
flow experiments were carried out in a machine 
built according to [ 171. The reaction was started by 
mixing the enzyme and substrate solutions 
(0.5 ml/syringe) and stopped by addition. of 5% 
trichloroacetic acid after different reaction times. 
The incubation time varied from 5-400 ms. 
Twelve different fractions corresponding to 
equally-spaced incubation times were obtained for 
each run. The [14C]tryptophanyl-tRNA coming 
from [14C]tryptophan was counted in a Bray scin- 
tillation mixture. The stopped-flow experiments 
were carried out with a Durrum-Gibson apparatus 
equipped with a fluorescence detector. A Corning 
C S 0.54 filter was used in the emission beam. The 
excitation wavelength was 295 nm. The presteady- 
state kinetics of aminoacylation of tRNA was 
studied under the experimental conditions of 
aminoacylation shown to give maximum steady 
state rate of reaction (10 mM ATP, 50 pM tryp- 
tophan, 5 pM tRNA, 1 mM free Mg2+, pH 8) at 
25°C [12]. These concentrations are nearly 
saturating for all substrates (& = 1.6 pM and 
18.5 ,uM for tryptophan, Kd = 1.4 mM for ATP- 
Mg2+ [18], Km = 0.3rM for tRNATm [5,6]). 
3. RESULTS AND DISCUSSION 
3.1. Quenched-flow experiments 
(a) The quenched-flow experiments were first 
carried out with tryptophanyl-tRNA synthetase 
preincubated with a stoichiometric amount of 
[‘4C]tryptophan and with an excess of ATP-Mg2+ 
in the presence of PPi, without tRNA (conditions 
a). Under these conditions a complex carrying 2 
tryptophanyl adenylates/mol enzyme has been 
shown to form [19]. Upon mixing this complex 
with a large excess of tRNA (5 PM) over the en- 
zyme (0.3 PM) in the presence of 10 mM ATP- 
Mg2+ and 50yM [14C]tryptophan an initial burst 
of [r4C]tryptophanyl-tRNA was observed, follow- 
ed by a slow formation of labelled tryptophanyl- 
tRNA in a pseudo steady-state reaction (fig.la). 
The appearance of a burst indicated that the 
reaction followed either a 2 step process; for exam- 
ple, that the 2 catalytic sites were carrying on the 
transfer of tryptophan at quite different rates; or, 
that there was a fast transfer of [14C]tryptophan 
followed by a steady state aminoacylation 
reaction. 
(b) The quenched-flow experiments were then 
carried out with tryptophanyl-tRNA synthetase 
preincubated under the same conditions as in a ex- 
cept that tryptophan was unlabelled (conditions b). 
In this case the tryptophanyl-adenylate enzyme 
complex was initially cold. When mixed with 
tRNA it could not lead to labelled tryptophanyl- 
tRNA. Fig.lb shows that when this complex was 
added as in a to tRNA in the presence of 10 mM 
ATP-Mg2+ and 50 ,uM [r4C]tryptophan a lag phase 
was observed, preceding the formation of 
[14C]tryptophanyl-tRNA in a pseudo steady-state 
similar to that previously obtained. Considering 
that the linear parts of curves a and b (fig.1) are 
likely to show the same process these data were not 
in agreement with the hypothesis that these linear 
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Fig. 1. Presteady-state kinetics of tRNA aminoacylation 
under quenched-flow conditions. The first syringe 
(0.5 ml) contained 0.6 PM enzyme, 20 mM ATP-Mg2+, 
1.2 /IM L-[14C]tryptophan (o), or unlabelled L- 
tryptophan (u) and 0.1 unit/ml inorganic 
pyrophosphatase. The second syringe (0.5 ml) contained 
100 PM L-[14C]tryptophan, 10 PM tRNATv. The third 
syringe (1 ml) contained 5% trichloroacetic acid. The 
mixture contained in the first syringe was allowed to 
incubate for 10 min at 25°C to ensure the formation of 
the tryptophanyl adenylate-enzyme complex. 
parts could correspond to a slow transfer following 
the fast one: under conditions b the unlabelled 
amino acid would not generate a labelled 
aminoacyl-tRNA. Furthermore, the amount of 
aminoacyl-tRNA formed in the linear part of the 
curve exceeded what could be expected from the 
enzyme concentration. 
The analytical expressions corresponding to 
curves a and b were therefore written on the basis 
of the following hypotheses: 
(1) The fast phase obtained under conditions a 
was the transfer of tryptophan. 
(2) The linear phase observed after 100 ms did 
correspond to a steady state formation of 
aminoacyl-tRNA. 
Scheme 1 depicts these hypotheses: 
Ej.W-AMP.tRNA A 
Et. WtRNA + AMP b , 
(+W+ATP+tRNA) 
Ei . W-AMP - tRNA + PPi + W-tRNA 
Ei refers to subunits 1 or 2 of the enzyme, 
W-AMP represents tryptophanyl adenylate and 
W-tRNA represents tryptophanyl-tRNA. In this 
scheme, kl corresponds to the rate of the transfer 
reaction and k2 corresponds to the rate resulting 
from all steps preceding or following the transfer, 
including the aminoacyl-tRNA dissociation from 
the enzyme and the adenylate formation. In such 
a scheme all substrates are expected to undergo 
fast pre-equilibrium with the enzyme and are con- 
sidered as saturating. 
Depending on the tryptophan (labelled or cold) 
used in the preincubation of the enzyme with ATP- 
Mg2+ the formation of total radioactive 
aminoacyl-tRNA (free and bound to the protein) 
should follow eq. (1) or (2). 
When tryptophan was labelled during the prein- 
cubation (conditions a): 
[W*-tRNA] = n[E] x 
klkzt k12 
kl + kz + (kl + kd2 
(1 - exp(- kl - kdt) 1 (1) 
When tryptophan was unlabelled during the 
preincubation (conditions b): 
[W*-tRNA] = n[E] *t + (k :;2,2 x 
1 2 
l -I 
(1 - exp(-kl-k2) + exp(-kit) - 1 
1 
(2) 
In eq. (1) and (2) n refers to the number of 
subunits carrying out the synthesis of 
tryptophanyl-tRNA and [E] to the total enzyme 
concentration. 
According to eq. (1) and (2) the straight lines 
taken as the steady state formation of aminoacyl- 
tRNA in curves a and b can be extrapolated back 
to time zero and define the positive burst ~1 and 
the negative burst ~22: 
~1 = n [E] k12 
(ki + kz)2 
2klkz + kz2 
a-2 = 
-n IE1 (kl + k2)2 
(conditions a) 
(conditions b) 
The amplitude between the two bursts is * = 
Tl - ;rz = n[E]. The determination of this 
amplitude should then lead to the titration of the 
active sites actually carrying out the transfer pro- 
cess, independently of any consideration about the 
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chemical or conformational nature of the steps of 
rate kl and kz. In particular k2 can be the combina- 
tion of the rates corresponding to several pro- 
cesses: activation of the amino acid, release of the 
aminoacyl-tRNA, isomerisation of the enzyme. 
The analysis of curves a and b from fig. 1 allow- 
ed us to obtain n = 0.95 + 0.15 and the rate con- 
stants kl and kg kl = 25 f 5 s-l, kz = 11 f 3 s-l. 
The step of rate kl is much faster than kcat, the 
steady state rate of formation of aminoacyl-tRNA. 
This latter rate is kcat = klkz/(kl + kz) = 7.6 s-l, 
in reasonable agreement with that obtained under 
normal steady state conditions (6.5 s-l [12]). kl is 
also significantly faster than the rate constant kz. 
These results suggest hat only one site could be 
titrated under the present conditions (n = 0.95) and 
that the transfer of tryptophan is not the limiting 
step in the overall aminoacylation ‘reaction. 
3.2. Stopped-flow experiments 
The formation of the tryptophanyl-adenylate 
enzyme complex is associated with a quenching of 
the fluorescence of the enzyme [19]. The reverse 
reaction (pyrophosphorolysis) restores the initial 
fluorescence [20]. The transfer reaction can also be 
expected to bring about an increase of the enzyme 
fluorescence since it corresponds to the destruction 
of the adenylate-enzyme complex. On the other 
hand, the formation of an ester bond on the car- 
boxylic group of tryptophan is known to strongly 
decrease the fluorescence of this amino acid [21]. 
Therefore, the pseudo steady-state aminoacylation 
of tRNA with tryptophan can be expected to give 
rise to a fluorescence quenching, preceded in the 
prestationary phase by a fluorescence increase 
when the protein is initially under the form of a 
tryptophanyl adenylate-enzyme complex. 
In the first stopped-flow experiments the 
aminoacylation was started by mixing the free en- 
zyme (1 PM) with all substrates (40 pM tryp- 
tophan, 5 mM ATP-Mg2+ and 5 pM tRNA) at 
time zero. Fig.2a shows that a continuous decrease 
of the fluorescence of the mixture was observed. 
This fluorescence levelled off after 5 s. This con- 
tinuous decrease can be interpreted as showing the 
steady state formation of tryptophanyl-tRNA 
since its rate was 6 s-l until the tRNA.concentra- 
tion became rate limiting (after 2 s). This rate was 
obtained under steady state conditions in [12]. 
In the second stopped-flow experiments the en- 
5mj ,4 
1 2 3 4 5 
Time k.1 
Fig.2. Presteady-state kinetics of tRNA aminoacylation 
under stopped-flow conditions. The first syringe (2 ml) 
contained 2 PM enzyme (a) or 2/rM enzyme, 1OOpM 
ATP-Mg2+, 5 /IM L-tryptophan and 0.1 units/ml 
inorganic pyrophosphatase (b). The second syringe 
(2 ml) contained 80pM L-tryptophan, 10 mM ATP- 
Mg2+ and 10pM tRNATW. In (b) the syringe mixture 
was allowed to incubate as in fig.1. The time course of 
the fluorescence change was recorded with two time 
bases. Rise time was 1 ms. 
zyme was initially preincubated in the presence of 
tryptophan, ATP and traces of inorganic 
pyrophosphatase (under conditions of adenylate 
formation [7]). It was then mixed at time zero with 
tRNA and with the same excess of tryptophan and 
ATP as in fig.2a. Fig.2b shows that an initial 
fluorescence rise was visible before the same quen- 
ching as in fig.2a eventually occurred. This initial 
rise was interpreted as showing the destruction of 
the adenylate-enzyme complex; i.e., as correspon- 
ding to the transfer of tryptophan from the 
adenylate to tRNA. The absence of such an initial 
fluorescence rise when all substrates were added to 
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the free enzyme suggests two conclusions: 
(1) This rise was specifically linked to the pre- 
formation of the adenylate; 
(2) There exists a step slower than the transfer, 
which occurs before it. 
The conclusions of the quenched-flow and of the 
stopped-flow data appear therefore to be 
consistent. 
A burst in the formation of the aminoacyl-tRNA 
preceding the establishment of the stationary state 
has already been observed for the yeast arginyl en- 
zyme (221, the B. stearothermophilus methionyl 
enzyme [23] and the yeast valyl enzyme [17] and is 
implicit in eq. (1). The finding that a single tryp- 
tophan molecule is transferred from the 
(adenylate)z-enzyme complex supports the obser- 
vation in [lo] suggesting half-of-the-sites reactivity 
in the aminoacylation reaction. The single K, of 
the aminoacylation under steady state conditions 
[9,12] should then correspond to the functioning 
of one site at a time in this reaction even though 
both tryptophanyl-adenylates were made by the 
enzyme [19]. 
In conclusion, these data are interpreted as 
showing that tryptophanyl-tRNA synthetase from 
beef pancreas presents the two following 
characteristics in the aminoacylation reaction: 
(1) Only one subunit operates at a time in the 
transfer of the amino acid; 
(2) The transfer step is not the limiting step in the 
overall aminoacylation. 
Since the adenylate synthesis in the absence of 
tRNA is much faster than the aminoacylation it 
seems necessary to conclude that a third process 
(isomerisation steps or something else) plays a 
determinant role in the rate of catalysis. 
Isomerisation steps have already been shown to 
constitute essential processes in the valine enzyme 
from yeast [34]. 
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